- Clinical Trials
- April 2024
- 60 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Report
- January 2022
- 200 Pages
Global
From €7284EUR$7,500USD£6,284GBP
- Report
- January 2022
- 60 Pages
Global
From €3836EUR$3,950USD£3,310GBP
- Drug Pipelines
- August 2018
- 113 Pages
Global
From €1943EUR$2,000USD£1,676GBP
- Report
- May 2022
- 70 Pages
Global
From €1943EUR$2,000USD£1,676GBP
The Visceral Pain Drug market is a subset of the Analgesics market, which is composed of drugs used to treat pain. Visceral Pain Drugs are used to treat pain caused by the stimulation of the internal organs, such as the stomach, intestines, and bladder. These drugs are typically used to treat chronic pain, such as that caused by cancer, and acute pain, such as that caused by surgery. Visceral Pain Drugs are typically administered orally, intravenously, or through a patch.
Common Visceral Pain Drugs include opioids, non-steroidal anti-inflammatory drugs (NSAIDs), and anticonvulsants. Opioids are used to treat moderate to severe pain, while NSAIDs are used to treat mild to moderate pain. Anticonvulsants are used to treat neuropathic pain.
Some companies in the Visceral Pain Drug market include Pfizer, GlaxoSmithKline, Merck, and Johnson & Johnson. Show Less Read more
